FDA issues Guidance for a clear Identification of pharmaceutical Companies
Recommendation
21-23 May 2025
Copenhagen, Denmark
Initial and Continuous Professional Training for GMP Auditors
Register now for ECA's GMP Newsletter
In our GMP News from September 2013 you learned about a draft of a FDA Guidance for Industry entitled "Specification of the Unique Facility Identifier (UFI) System for Drug Establishment Registration". This document's goal was to clearly identify pharmaceutical sites. The draft comprised (manageable) five pages - including the cover page. And in terms of volume this didn't change. However, some of the alternatives still mentioned in the draft, are not stated any longer - as one can find out when contacting the authority in these cases. The method now wanted is a registration by a D-U-N-S- (Data Universal Numbering System) number. This number - which is a 9-digit code - is supplied by the company Dun & Bradstreet.
To find out more please see the complete Guidance for Industry "Specification of the Unique Facility Identifier (UFI) System for Drug Establishment Registration".
Related GMP News
05.02.2025European Shortages Monitoring Platform (ESMP) goes live
05.02.2025The ICH Q9 Briefing Package - a Forgotten Document?
23.01.2025FDA proposes Standardized Testing for Asbestos in Talc-Containing Cosmetic Products
16.01.20252nd Version of the Union list of Critical Medicines published
16.01.2025Securing Europe's Drug Supply: How EDSForm is Addressing Medicine Shortages